Rafael Maarek Tomorrow! April 9, 2025 (Wednesday) Time: 8:00 - 9:00 AM Title: Analyzing the Neurophysiologic Effects of IA Verapamil During Angiographic Treatment of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Session: P11: Neighbor 5, Poster 005
And last two up for us:
Justin Wheelock Today! April 8, 2025 (Tuesday) Time: 8:00 - 9:00 AM Title: Accounting for Death in the Prediction of Post-intracerebral Hemorrhage Epilepsy Using Quantitative Electroencephalogram and Neuroimaging Session: P8: Neighb 7, Monitor 002
Keeping it up at AAN!
Tomorrow:
Sithmi Jayasundara
8:00 - 9:00 AM (Sess: P5: Neighb 13, P018)
Title: Analyzing Nimodipine-Associated Hemodynamic and Electrophysiologic Changes and Functional Outcomes in Aneurysmal Subarachnoid Hemorrhage
So excited to support my students at AAN this year! First up: David Vargas
2Date: Today 4/6
3Time: 8:00 - 9:00 AM
4Title: Assessing the Effects of Cerebral Autoregulation and Neurophysiologic Parameters on Outcomes in aSAH
5Session: P2: Neighb 13, Poster 016
I need people to understand how difficult it is to get an NIH grant. You spend months writing a proposal, following strict guidelines that include a detailed multiyear budget, bios of everyone on your team, plans for participant safety & ethical conduct. Then you send it off -1/n
See our work with @wtkimberly in The Lancet Neurology! The CHARM trial represents a significant step toward tackling cerebral edema in large hemispheric strokes. @YaleMed@Yale@AHAScience@nih_strokenet
https://t.co/r1v4WFaVsz
While challenges remain, the findings inspire hope and pave the way for targeted, life-changing therapies. The future is bright for stroke care!
Very excited to see this project in print.
Wonderful multi-institutional collaboration evaluating sex differences in severity and outcome of #IntracerebralHemorrhage.
I'm sure there will be many other chapters to come.
Paper:
https://t.co/f5TMEiF8EP
Great, interesting editorial by @ProvencioJavier about the “blind spots” in neurocritical care. Javier astutely points out that NCC is unique in that it originated from 3 distinct specialties — neurology, neurosurgery, and critical care medicine — and this “mash up” may lead to inconsistencies.
In this case, why do we consistently monitor ICP after SAH, TBI and ICH, nut do so rarely in comatose pts with bacterial meningitis?
Give it a read!
https://t.co/l8hYN1k2x3
Absolutely treasured having the wonderfully talented @caseyalbin visit us @NeurologyYale@YaleNeuroICU for Grand Rounds today! Always enjoy hearing you talk about how sim and social media can advance neurology 🧠❤️
The concept of #CodeICH is already having a huge impact!
Here's a brilliant paper by @sheth_kevin using the @StrokeAHA_ASA GWTG database, looking at >9,000 patients with anticoagulation-associated #ICH. Massive.
Median DTN time 82 minutes. (Not bad, actually, better than I would have guessed).
Door-to-needle <60 minutes = lower mortality.
Time = brain, especially for ICH!
How good is your center? Please share if you are trying to get ICH time metrics going at your stroke center. Let's learn from each other.
@ClaudeHemphill@JoshGoldsteinMD@sashkind
https://t.co/V5b72rpzRC
Very excited about this new stage!
And very happy to share this stage with my colleague, friend and now partner, the one and only, @drejgilmore.
@YaleNeuroICU
Big announcement #neurotwitter🥁🥁🥁
We have a new position at Continuum: Associate Editor for Media Engagement
And I’m very proud to announce that Dr. Casey Albin (the one and only @caseyalbin) will be the inaugural editor in this role!!!
So what can you expect next?